Primary pigmented nodular adrenocortical disease
| Primary pigmented nodular adrenocortical disease
| |
|---|---|
| Synonyms | PPNAD
|
| Specialty | Endocrinology |
| Symptoms | Cushing's syndrome, hypertension, weight gain |
| Complications | Diabetes mellitus, osteoporosis |
| Usual onset | Usually in childhood or adolescence |
| Duration | Chronic
|
| Causes | Genetic mutations, often associated with Carney complex |
| Risk factors | Family history of Carney complex |
| Diagnosis | CT scan, MRI, adrenal vein sampling, genetic testing |
| Differential diagnosis | Adrenal adenoma, Adrenal carcinoma, Cushing's disease
|
| Treatment | Adrenalectomy, medications
|
| Prognosis | Variable, depends on extent of disease and response to treatment |
| Frequency | Rare
|
Primary pigmented nodular adrenocortical disease (PPNAD) is a rare cause of Cushing's syndrome, characterized by small, pigmented nodules in the adrenal glands. It is often associated with Carney complex, a genetic condition that includes multiple neoplasias and other abnormalities.
Presentation[edit]
Patients with PPNAD typically present with symptoms of Cushing's syndrome, including hypertension, weight gain, muscle weakness, and skin changes. The disease often manifests in childhood or adolescence.
Pathophysiology[edit]
PPNAD is caused by genetic mutations that lead to the formation of pigmented nodules in the adrenal cortex. These nodules produce excess cortisol, leading to the symptoms of Cushing's syndrome. The condition is frequently associated with Carney complex, which is caused by mutations in the PRKAR1A gene.
Diagnosis[edit]
Diagnosis of PPNAD involves a combination of imaging studies and laboratory tests. CT scans and MRIs can reveal the presence of adrenal nodules. Adrenal vein sampling may be used to confirm the source of excess cortisol production. Genetic testing can identify mutations associated with Carney complex.
Treatment[edit]
The primary treatment for PPNAD is surgical removal of the adrenal glands (adrenalectomy). In some cases, medications that inhibit cortisol production may be used. Lifelong follow-up is necessary to monitor for recurrence and manage any complications.
Prognosis[edit]
The prognosis for patients with PPNAD varies. Early diagnosis and treatment can improve outcomes, but the disease can be challenging to manage due to its chronic nature and potential complications.
